peptidewatch

Why Pharma peptides are better than research use only/Compounded peptides A Thread

BPC-157 KILLED chronic pain in animal studies. And fixed the damage causing it. Not opioids. Not NSAIDs. A peptide from your own stomach. Published. Peer-reviewed. Tendon pain — resolved. Ligament pain — resolved. Joint pain — resolved. Muscle tears — healed. Nerve pain — reduced. Your body’s pain signals served a purpose. They were telling you damage existed. BPC-157 fixed the damage. Opioids can’t do that. They numb the signal. That’s why you can’t feel your feet. That’s why you get constipated. That’s why you get addicted. Opioids carpet bomb your nervous system. This peptide rebuilt the source. Most of this data is preclinical — rats and mice, not humans. But one study went further. 12 patients with chronic knee pain. 7 got pain relief that lasted over 6 months. Not in a lab. In living humans. In another study BPC-157 COUNTERACTED corticosteroid damage — the same cortisone shots your doctor pushes — while rebuilding the tendon the cortisone was destroying. Not a cure. Not a replacement for acute medical care. But the data exists and nobody talks about it. NSAIDs cause 100,000 hospitalizations a year. BPC-157 reverses the gut damage NSAIDs create. BPC-157 also rebuilds the tissue causing the pain in the first place. Two mechanisms. One peptide your body already makes. $100 a month. The pain industry doesn’t sell repair. It sells management. Think about why. Everything you need below ↓

I get so many pitch decks now for peptide companies now and basically all of them 1) exclusively focus on their customer acquisition costs, their UGC/video content including AI generated marketing pipelines, and affiliate marketing strategy 2) talk about how fast their turnaround time is to patients and how broad their catalog of peptides are 3) do not talk at all about monitoring patients post prescription 4) they all say they work with the top suppliers to provide legitimacy but don't really have a clear methodology for how they're doing this (esp with so many steps between securing the in ingredient, to shipping, to compounding) I understand why peptides are popular - but I don't think having more companies who effectively are marketing/dropshipping companies while offloading liability and adverse events to the doctors is the right direction for healthcare

There is a topic coming up again and again in health right now, and peptides are at the centre of it which has made me want to understand what is actually going on… When I told my team I wanted to do an episode on peptides, they sent me a long list of doctors I could speak to but there was one person they kept coming back to. That person was Dr Alex Tatum. And after this conversation, I understood why. Alex has spent over a decade studying this space, and one of the reasons I wanted him on is because he has a rare ability to explain complex things in a way that actually makes sense. I didn’t have a clear idea of what peptides even were before we spoke but now I do. Alex explained to me that peptides are tools and like any tool, they only make sense when you know what you’re trying to build.

Trump: "I was surprised to hear about the antidepressants. I assume they'd be better. That's not very good. So Bobby, you're gonna push it hard?"